The World Health Organization (WHO) says it will keep its alert for mpox at the highest level amid a surge in cases. A WHO committee made up of about a dozen independent experts made the decision at a meeting in Geneva on Friday,

The World Health Organization Tuesday granted emergency use authorization for the second mpox vaccine. The LC16m8 vaccine from Japan's KM Biologics is the second since WHO declared mpox a health emergency in August.

Decision comes as Mpox cases surge, particularly with the spread of the clade Ib variant beyond its origin in the Democratic Republic of Congo to neighbouring African nations, Europe, and Asia

There have been more than 46,000 suspected cases across Africa and more than 1,000 suspected deaths; Canada has reported its first case of clade 1 mpox; the WHO has now approved of a Japanese mpox vaccine for use in children The Mpox outbreak continues to represent a public health emergency,